Lessons Learned in Clinical Decision Support: Over-alerting Tejal K. Gandhi, MD MPH Director of Patient Safety Brigham and Women’s Hospital Assistant Professor.

Slides:



Advertisements
Similar presentations
Improving Office Care for Chest Pain Thomas D. Sequist, MD MPH Associate Professor of Medicine and Health Care Policy Brigham and Women ’ s Hospital, Division.
Advertisements

Pharmacy department Configuring drug : drug interactions – don’t assume…. Anna Bunch IM&T and ePrescribing Pharmacist Lead 15 th October 2014.
Decision Support for Quality Improvement
UAMC – Discharge Medication Optimization Lauren Miller, PharmD. Instructor University of Arizona College of Pharmacy Clinical Staff Pharmacist Ambulatory.
Unit 6c: Alerts and Clinical Reminders Decision Support for Quality Improvement This material was developed by Johns Hopkins University, funded by the.
1 Implementing GRADE Experience of the Tufts Center for Kidney Disease Guideline Development and Implementation Tufts Medical Center, Boston MA Guideline.
Meredith Cook Mercer COPHS August, Beers Criteria AGS and interdisciplinary panel of 11 experts in geriatrics and pharmacotherapy 53 medications.
Drug Utilization Review (DUR)
Safety, Quality and Information Technology and NHII David W. Bates, Medical Director of Clinical and Quality Analysis, Partners Healthcare Chief, Division.
PICO Presentation July 29, 2011 Jaclyn Wakita Pharmacy Resident University Hospital of Northern British Columbia.
Penetration and Availability of Clinical Decision Support in Commercial Systems Clinical Decision Support - The Road Ahead Chapter 7.
ICU Clinical Information Management System An Investigation for a Pediatric Intensive Care Unit Steven Sousa Ann Thompson.
Simplification Tactics Dr. Saeed Shiry Amirkabir University of Technology Computer Engineering & Information Technology Department.
Cornelius Dial, RPh Order Checks 1. 2 Learning Objectives Become familiar with the Order Checking feature and how it is triggered Examine the Order Check.
Chapter 2 Electronic Health Records
Evidence-Based Research Group Project Marcie Chenette Dulcebelle Pearson Melanie Underwoood Marcie Chenette Dulcebelle Pearson Melanie Underwoood.
MEANINGFUL USE UPDATE 2014 Mark Huang, M.D. Chief Medical Information Officer Rehabilitation Institute of Chicago Associate Professor Department of PM.
1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.
Alerts in Clinical Information Systems: Building Frameworks and Prototypes Project presented by Rolf Wipfli Project team: Rolf Wipfli Prof. Christian Lovis.
Medical Informatics "Medical informatics is the application of computer technology to all fields of medicine - medical care, medical teaching, and medical.
Quality Improvement Decision Support for Quality Improvement Lecture b This material (Comp12_Unit5b) was developed by Johns Hopkins University, funded.
Unit 6.2: Clinical Decision Support Systems that Help Improve Quality Decision Support for Quality Improvement Component 12/Unit 6.21Health IT Workforce.
Health Information Technology: EHRs and Beyond Thomas Sequist, MD MPH.
The Role of Clinical Pharmacists in Outpatient Psychiatric Clinics Mary A. Gutierrez, Pharm.D., BCPP Associate Professor of Clinical Pharmacy University.
Order Checks. Learning Objectives Become familiar with the Order Checking feature and how it is triggered Examine the Order Check Parameters where system.
Medication Reconciliation: The Inpatient Hospitalist Perspective
Quantitative Evaluation of Drug Name Safety Using Close-to-Reality Simulated Pharmacy Practice Sean Hennessy, PharmD, PhD Assistant Professor of Epidemiology.
Use of Information Technology for Precision Performance Measurement and Focused Quality Improvement David W. Baker, MD MPH Chief, General Internal Medicine.
The Antidote to Alert Fatigue May 26, 2010 Best Ever Medical Center Best City, IL MMI – 406: Decision Support Systems and Healthcare Suzi Birz, Nicki.
Summary of Recent Literature 2011 Dr. Alexandra Papaioannou.
Resident Research Conference November 20, 2013 Alex Bryant Physician handling of medication order alerts.
So You Want to Do CDS A C-Level Introduction to Clinical Decision Support.
Human Factors Considerations for Contraindication Alerts Heleen van der Sijs, Imtiaaz Baboe, Shobha Phansalkar Heleen van der Sijs, PharmD PhD Clinical.
IOM Workshop on Standards for Clinical Guidelines Monday, January 11, 2010 Elizabeth Mort, MD, MPH Massachusetts General Hospital Partners HealthCare,
What do we know about overall trends in patient safety in the USA? Patrick S. Romano, MD MPH Professor of Medicine and Pediatrics University of California,
Incorporating HCT Tools/Functions into Electronic Health Record Systems Stuart T. Weinberg, MD, FAAP Assistant Professor Departments of Biomedical Informatics.
Slaying the HIT Dragon David Bates, MD, MSc Chief, Division of General Internal Medicine, Brigham and Women’s Hospital Medical Director of Clinical and.
Health Management Information Systems
E-prescribing in community- based practices: successes and barriers Michael A Fischer, M.D., M.S. Division of Pharmacoepidemiology and Pharmacoeconomics.
STRATEGIES TO REDUCE COMPUTERIZED ALERTS IN AN ELECTRONIC PRESCRIBING SYSTEM MELISSA BAYSARI, JOHANNA WESTBROOK, BRIAN EGAN, RICHARD DAY.
Order Checks. Order checking Component of order entry Based on a system of rules, which review orders to see if they meet defined criteria. If they meet.
Beyond ePrescribing Factors Influencing Patient Safety in Medical Group Practices - September 26 th, 2007 AHRQ 2007: Improving Healthcare, Improving Live.
SHIRE Evaluation of Clinical Information Technology CLC 11/17/04 Jeff Newman MD MPH Sutter Health Institute for Research & Education (SHIRE)
Clinical Decision Support Computerized Provider Order Entry (CPOE) 1.
Medication Safety Ambulatory Medication Safety Effie Brickman, Director Ambulatory Medication Safety
Unit 6a: Clinical Decision Support System (CDSS) basics Decision Support for Quality Improvement This material was developed by Johns Hopkins University,
New Jersey Institute of Technology Enterprise Development Center (EDC) 211 Warren Street, Newark, NJ Phone: Fax:
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Value of Pharmacy Services January 31 st (A), 2011 J. Hirsch, Ph.D. SSPPS – 207 Introduction to Health Care Systems and Policy.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Computerized Physician Order Entry (CPOE), Process, Costs and Benefits Joe Shaffer, MS Alberto Coustasse, DrPH, MD Graduate School of Management, College.
Tejal Gandhi, MD MPH Associate Professor of Medicine, Harvard Medical School Chief Quality and Safety Officer, Partners Healthcare Improving Hospital Medication.
REFERENCES & ACKNOWLEDGMENTS Repurposing Decision Support Data to Detect Prescribing Errors—An Application for Quality Measurement David L. Chin, Ashley.
Emergency Physician Attitudes and Knowledge of ACEP’s Choosing Wisely Recommendations Thomas Nguyen, MD 1, Lynne D. Richardson, MD 2, Jeremiah D. Schuur,
Patient Safety and Quality: Where Does Health Care in Schools Fit In? Howard Bauchner, M.D. Professor of Pediatrics & Public Health Director, Division.
ADVERSE DRUG EVENT (ADE) Driver Diagram OHA HEN 2.0.
Pharmaceutical industry interactions in family medicine residencies have decreased since 2008 Steven R. Brown, MD, David V. Evans, MD, Adriane Fugh-Berman,
Using Technology to Support Evidence Based Practice
1st International Online BioMedical Conference (IOBMC 2015)
What Are Clinical Trials?
Efficient Remediation of Terms Inactivated by Dictionary Updates
Computerized Physician Order Entry and Medication Safety
The Future of Improvement in Medication Safety
Improving Anticoagulant Compliance With Neuraxial Anesthesia
Daniel R. Masys, M.D. Professor and Chair
Presenter : Wayne Chen 陳旭瑋
Benefits for Patients, Providers and Payers
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Applying the Goldilocks Principle to Clinical Decision Support
Presentation transcript:

Lessons Learned in Clinical Decision Support: Over-alerting Tejal K. Gandhi, MD MPH Director of Patient Safety Brigham and Women’s Hospital Assistant Professor in Medicine Harvard Medical School

Overriding of Alerts Studies have shown that MDs override clinical decision support alerts a large percent of the time Studies have shown that MDs override clinical decision support alerts a large percent of the time  88% of inpatient DDI alerts overridden (Payne et al. Proc AMIA 2002)  83% of inpatient drug-allergy alerts (Abookire et al. Proc AMIA 2000)  89% of outpatient high severity DDI alerts and 91% of outpatient drug-allergy alerts (Weingart et al. Arch Intern Med 2003)

Are Overrides Appropriate? 7,761 drug-allergy alerts in BWH inpatients, Aug-Oct ,761 drug-allergy alerts in BWH inpatients, Aug-Oct 2002 Alerts were overridden 80% of the time Alerts were overridden 80% of the time In chart review of 300 overrides, all were clinically justified In chart review of 300 overrides, all were clinically justified  Evidence that we are over-alerting Only 6% of alerts were triggered by an exact match between drug ordered and drug in allergy list (lots of potential noise) Only 6% of alerts were triggered by an exact match between drug ordered and drug in allergy list (lots of potential noise) Hsieh et al. JAMIA 2004

Alerts Triggered by Exact Drug-Allergy Matches are Rare Ordered drug Hydromorphone ( DILAUDID ® ) (N=18) Drug in allergy list  Codeine (39%)  Oxycodone (22%)  Meperidine (22%)  Morphine (17%)  Hydromorphone (0%)

Alerts Triggered by Exact Drug-Allergy Matches are Rare Ordered drug Furosemide ( LASIX ® ) (N=18) Hydrochlorothiazide (N=4) Drug in allergy list  ‘Sulfa’ (95%)  Furosemide (5%)  ‘Sulfa’ (100%)  Hydrochlorothiazide (0%)

Allergy Alerting Recommendations Need better specificity of alerts to avoid false positives Need better specificity of alerts to avoid false positives  E.g. requiring exact matches for certain classes  Good news: FDB recently removed lasix/HCTZ – sulfa interaction

Overall Alerting Issues Need more studies to maximize effectiveness of alerts/ minimize over-alerting Need more studies to maximize effectiveness of alerts/ minimize over-alerting Issue of how best to display the messages Issue of how best to display the messages  Need to learn from other industries (industrial engineering)

Drug-Pregnancy Level 1

Potential Strategies to Improve Alerting Creation of streamlined knowledge bases Creation of streamlined knowledge bases  Only essential content  Balance between sensitivity and specificity Tiering of alerts is also a possibility Tiering of alerts is also a possibility  Hard stop  Interruptive  Non-interruptive Minimizing interruptions Minimizing interruptions

Impact of Reduced Alerting on Override Rates Study in the ambulatory setting Study in the ambulatory setting Decision support included Decision support included  Duplicate drug  Drug-disease  Drug-drug  Drug-lab  Drug-pregnancy Shah et al. JAMIA 2006

Knowledge base streamlining Expert panel Expert panel  Physicians, pharmacists, informaticians Reviewed sources Reviewed sources  Vendor knowledge-bases, pre-existing locally created KBs, literature  Removed certain alerts and tiered the rest

Alert tiers Level 1 – Potentially life-threatening Level 1 – Potentially life-threatening  E.g., erythromycin - diltiazem -> V-fib  “Hard stop” – couldn’t proceed Level 2 – Potential for serious injury Level 2 – Potential for serious injury  Rizatriptan - linezolid -> serotonin syndrome  Interruptive, required a reason Level 3 – Use w/ caution Level 3 – Use w/ caution  Warfarin – levofloxacin -> increased PT  Noninterruptive

Actions w/ level 2 alerts Cancel Cancel  Do not proceed with order Modify, examples include Modify, examples include  Alter the problem list  Discontinue the pre-existing drug  Hold the other medication “Accept” defined as “cancel” or “modify” “Accept” defined as “cancel” or “modify” “Override” defined as not accept “Override” defined as not accept

Results Final knowledge base Final knowledge base  2% level 1 63% level 2, 35% level 3 18,115 alerts 18,115 alerts  12,933 non-interruptive (71%)  5,182 interruptive (29%) Of 5,182 interruptive alerts Of 5,182 interruptive alerts  3475 (67%) accepted

Interruptive alerts AlertNAcceptedOverridden Duplicate class 3,875 2,695 (77%) 910 (23%) Drug-drug (42%) 627 (58%) Drug-disease19 10 (53%) 9 (47%) Drug-lab92 37 (40%) 55 (60%) Drug-pregnancy (10%) 106 (90%) Total5182 3,475 (67%) 1,707 (33%)

Summary of Reduced Alerting Study Can reduce alert burden by streamlining and tiering the knowledge base Can reduce alert burden by streamlining and tiering the knowledge base Concept of a “non-interruptive” alert may be helpful Concept of a “non-interruptive” alert may be helpful Still need more research on what is optimal level of alerting Still need more research on what is optimal level of alerting  “Are we missing things” is always the worry

Non-interruptive alerts Alert N (% of all alerts in that category) Duplicate drug 0 (0%) Drug-drug 3547 (77%) Drug-disease 24 (56%) Drug-lab 4,444 (98%) Drug-pregnancy 4,918 (98%) Total 12,933 (71%)

Impact of Non-Interruptive Alerts Drilled down into the drug-lab alerts Drilled down into the drug-lab alerts No difference in lab ordering between control and intervention groups No difference in lab ordering between control and intervention groups Is it a user interface issue or are non-interruptive alerts just not effective? Is it a user interface issue or are non-interruptive alerts just not effective? Cost- benefit issue Cost- benefit issue  Minimize interruptions so higher risk alerts are accepted more often… yet little benefit seen with non-interruptive alerts

Impact of Tiering on Inpatient DDI Alerts Two academic medical centers Two academic medical centers Same knowledge base Same knowledge base Site A used 3 tiers Site A used 3 tiers Site B had all of the alerts as interruptive (Level 2) Site B had all of the alerts as interruptive (Level 2) Overall alert acceptance higher at tiered site (29% vs 10%, p<.001) Overall alert acceptance higher at tiered site (29% vs 10%, p<.001) Paterno, et al. Unpublished data.

Tiered Inpatient DDI Acceptance Rates Level 1 Acceptance rates Level 1 Acceptance rates  100% (hard stop) vs 34% (not a hard stop) Level 2 Acceptance rates Level 2 Acceptance rates  29% vs 11%  Likely higher at tiered site since less alert fatigue because fewer interruptive alerts

Conclusions Streamlined knowledge bases and tiered alerting have higher acceptance rates Streamlined knowledge bases and tiered alerting have higher acceptance rates  Especially for very high risk alerts Non-interruptive alerts may have little value Non-interruptive alerts may have little value What is our ideal acceptance rate?? Sensitivity/specificity? Best way to display? What is our ideal acceptance rate?? Sensitivity/specificity? Best way to display? More work needs to be done to maximize the clinical benefits More work needs to be done to maximize the clinical benefits Sharing of streamlined knowledge should be widespread Sharing of streamlined knowledge should be widespread  No need to reinvent the wheel